Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection

Background Limited literature exists that evaluated outcomes of kidney transplant–eligible patients who are having dialysis and who are undergoing valve replacement. Our main objective in this study was to compare mortality, reoperation, and bleeding episodes between bioprosthetic and mechanical val...

Full description

Bibliographic Details
Main Authors: David K. Ngendahimana, Salil V. Deo, Varun Sundaram, Krista L. Lentine, Charles A. Herzog, Laith Al Dahabreh, Titte R. Srinivas, Kenneth D. Chavin, Nagaraju Sarabu
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.018971
_version_ 1818315299275931648
author David K. Ngendahimana
Salil V. Deo
Varun Sundaram
Krista L. Lentine
Charles A. Herzog
Laith Al Dahabreh
Titte R. Srinivas
Kenneth D. Chavin
Nagaraju Sarabu
author_facet David K. Ngendahimana
Salil V. Deo
Varun Sundaram
Krista L. Lentine
Charles A. Herzog
Laith Al Dahabreh
Titte R. Srinivas
Kenneth D. Chavin
Nagaraju Sarabu
author_sort David K. Ngendahimana
collection DOAJ
description Background Limited literature exists that evaluated outcomes of kidney transplant–eligible patients who are having dialysis and who are undergoing valve replacement. Our main objective in this study was to compare mortality, reoperation, and bleeding episodes between bioprosthetic and mechanical valve procedures among kidney transplant–eligible patients who are having dialysis. Methods and Results We studied 887 and 1925 dialysis patients from the United States Renal Data System, who underwent mitral valve replacement and aortic valve replacement (AVR) after being waitlisted for a kidney transplant (2000–2015), respectively. Time to death, time to reoperation, and time to bleeding requiring hospitalizations were compared separately for AVR and mitral valve replacement. Kaplan–Meier survival curves, Cox proportional hazards model for time to death, accelerated time to event model for time to reoperation, and counting process model for time to recurrent bleeding were used. There were no differences in mortality (hazard ratio [HR], 0.92; 95% CI, 0.77–1.09) or risk of reoperation or risk of significant bleeding events between bioprosthetic and mechanical mitral valve replacement. However, mechanical AVR was associated with a modestly significant less hazard of death (HR, 0.83; 95% CI, 0.74–0.94) compared with bioprosthetic AVR. There were no differences in time to reoperation, or time to significant bleeding events between bioprosthetic and mechanical AVR. Conclusions For kidney transplant waitlisted patients who are on dialysis and who are undergoing surgical valve replacement, bioprosthetic and mechanical valves have comparable survival, reoperation rates, and bleeding episodes requiring hospitalizations at both mitral and aortic locations. These findings emphasize that an individualized informed decision is recommended when choosing the type of valve for this special group of patients having dialysis.
first_indexed 2024-12-13T09:03:20Z
format Article
id doaj.art-785231fcb5a449089e611f10c629d319
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-13T09:03:20Z
publishDate 2021-03-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-785231fcb5a449089e611f10c629d3192022-12-21T23:53:07ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802021-03-0110510.1161/JAHA.120.018971Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve SelectionDavid K. Ngendahimana0Salil V. Deo1Varun Sundaram2Krista L. Lentine3Charles A. Herzog4Laith Al Dahabreh5Titte R. Srinivas6Kenneth D. Chavin7Nagaraju Sarabu8National Center for PTSD Veterans Health Administration Menlo Park CADivision of Cardiac Surgery Louis Stokes Veterans Affairs Medical Center Cleveland OHDivision of Cardiology Department of Medicine University Hospitals Cleveland Medical Center Cleveland OHCenter for Abdominal Transplantation Saint Louis University St. Louis MODivision of Cardiology Department of Internal Medicine Hennepin Healthcare and University of Minnesota Minneapolis MNTransplant Institute University Hospitals Cleveland Medical Center Cleveland OHTransplant Institute University Hospitals Cleveland Medical Center Cleveland OHTransplant Institute University Hospitals Cleveland Medical Center Cleveland OHTransplant Institute University Hospitals Cleveland Medical Center Cleveland OHBackground Limited literature exists that evaluated outcomes of kidney transplant–eligible patients who are having dialysis and who are undergoing valve replacement. Our main objective in this study was to compare mortality, reoperation, and bleeding episodes between bioprosthetic and mechanical valve procedures among kidney transplant–eligible patients who are having dialysis. Methods and Results We studied 887 and 1925 dialysis patients from the United States Renal Data System, who underwent mitral valve replacement and aortic valve replacement (AVR) after being waitlisted for a kidney transplant (2000–2015), respectively. Time to death, time to reoperation, and time to bleeding requiring hospitalizations were compared separately for AVR and mitral valve replacement. Kaplan–Meier survival curves, Cox proportional hazards model for time to death, accelerated time to event model for time to reoperation, and counting process model for time to recurrent bleeding were used. There were no differences in mortality (hazard ratio [HR], 0.92; 95% CI, 0.77–1.09) or risk of reoperation or risk of significant bleeding events between bioprosthetic and mechanical mitral valve replacement. However, mechanical AVR was associated with a modestly significant less hazard of death (HR, 0.83; 95% CI, 0.74–0.94) compared with bioprosthetic AVR. There were no differences in time to reoperation, or time to significant bleeding events between bioprosthetic and mechanical AVR. Conclusions For kidney transplant waitlisted patients who are on dialysis and who are undergoing surgical valve replacement, bioprosthetic and mechanical valves have comparable survival, reoperation rates, and bleeding episodes requiring hospitalizations at both mitral and aortic locations. These findings emphasize that an individualized informed decision is recommended when choosing the type of valve for this special group of patients having dialysis.https://www.ahajournals.org/doi/10.1161/JAHA.120.018971end‐stage renal diseasekidney transplantsurvivalUnited States Renal Data Systemvalve replacement
spellingShingle David K. Ngendahimana
Salil V. Deo
Varun Sundaram
Krista L. Lentine
Charles A. Herzog
Laith Al Dahabreh
Titte R. Srinivas
Kenneth D. Chavin
Nagaraju Sarabu
Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
end‐stage renal disease
kidney transplant
survival
United States Renal Data System
valve replacement
title Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
title_full Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
title_fullStr Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
title_full_unstemmed Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
title_short Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
title_sort outcomes of surgical mitral and aortic valve replacements among kidney transplant candidates implications for valve selection
topic end‐stage renal disease
kidney transplant
survival
United States Renal Data System
valve replacement
url https://www.ahajournals.org/doi/10.1161/JAHA.120.018971
work_keys_str_mv AT davidkngendahimana outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT salilvdeo outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT varunsundaram outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT kristallentine outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT charlesaherzog outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT laithaldahabreh outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT tittersrinivas outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT kennethdchavin outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT nagarajusarabu outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection